Annotation Detail

Information
Associated Genes
PRPS1
Associated Variants
PRPS1 S103I
PRPS1 S103I
Associated Disease
childhood B-cell acute lymphoblastic leukemia
Source Database
CIViC Evidence
Description
Lentiviral-mediated overexpression of PRPS1 S103T in Reh cells resulted no difference in response to Methotrexate, Cytarabine, Daunorubicin, or L-Asparginase compared to empty vector and wildtype PRPS1 overexpression controls as indicated similar cytotoxicity curves and IC50s.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/7924
Gene URL
https://civic.genome.wustl.edu/links/genes/4566
Variant URL
https://civic.genome.wustl.edu/links/variants/2927
Rating
3
Evidence Type
Predictive
Disease
Childhood B-cell Acute Lymphoblastic Leukemia
Evidence Direction
Does Not Support
Drug
Methotrexate,Cytarabine,Daunorubicin,Asparaginase
Evidence Level
D
Clinical Significance
Resistance
Pubmed
25962120
Drugs
Drug NameSensitivitySupported
AsparaginaseResitance or Non-Reponsefalse
CytarabineResitance or Non-Reponsefalse
DaunorubicinResitance or Non-Reponsefalse
MethotrexateResitance or Non-Reponsefalse